Treatment tolerability and outcomes in elderly patients with head and neck cancer.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
03 2021
Historique:
received: 02 05 2020
revised: 03 11 2020
accepted: 09 11 2020
pubmed: 23 2 2021
medline: 1 7 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

The number of elderly patients with head and neck squamous cell carcinoma (HNSCC) continues to grow. Management of this cohort remains poorly defined. We investigated treatment tolerability and clinical outcomes in this underrepresented population. We identified patients aged ≥70 with nonrecurrent, nonmetastatic HNSCC treated curatively from 2007-2018 and analyzed clinical covariates. Two hundred and twenty patients with a median age of 75 (interquartile range:72-80) were identified. Age and comorbidities were not correlated with toxicity (P ≥ .05). Patients who experienced a treatment interruption had significantly greater weight loss (P = .042) and worse overall survival (OS) (P < .001), but not worse disease-specific survival (P = .45), or locoregional control (P = .21). Treatment interruptions were associated with weight loss and worse OS, but not disease related outcomes, suggesting an interruption in the elderly may be a surrogate for another issue. In sum, our data should guide clinical trial design to benefit this growing, neglected cohort.

Identifiants

pubmed: 33615611
doi: 10.1002/hed.26548
pmc: PMC9521799
mid: NIHMS1833023
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

858-873

Subventions

Organisme : NIA NIH HHS
ID : P30 AG028741
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001434
Pays : United States
Organisme : Claude D. Older Americans Independent Pepper Center at the Icahn School of Medicine
ID : 5P30AG028741-07

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Oncologist. 2013;18(5):568-78
pubmed: 23635557
Eur J Cancer. 1996 Nov;32A(12):2075-81
pubmed: 9014748
Korean J Intern Med. 2019 Jan;34(1):156-164
pubmed: 29466848
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Radiother Oncol. 2003 Oct;69(1):37-42
pubmed: 14597355
Eur Arch Otorhinolaryngol. 2007 Apr;264(4):415-22
pubmed: 17102957
J Geriatr Oncol. 2013 Jul;4(3):262-70
pubmed: 24058388
Rays. 1997 Jan-Mar;22(1 Suppl):53-6
pubmed: 9250015
PLoS One. 2013 Jul 15;8(7):e68660
pubmed: 23869226
J Clin Oncol. 2006 Mar 1;24(7):1105-11
pubmed: 16505430
Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1289-95
pubmed: 18086974
Eur Arch Otorhinolaryngol. 2019 May;276(5):1475-1486
pubmed: 30830300
World J Gastroenterol. 2011 Feb 28;17(8):1004-8
pubmed: 21448351
BMJ Qual Saf. 2019 Apr;28(4):338-344
pubmed: 30100565
Radiat Oncol. 2015 Apr 18;10:93
pubmed: 25896830
Ann Surg Oncol. 2007 Apr;14(4):1449-57
pubmed: 17235712
Acta Oncol. 2013 Feb;52(2):285-93
pubmed: 23320773
Oral Oncol. 2002 Feb;38(2):187-94
pubmed: 11854067
Can Fam Physician. 2015 Apr;61(4):337-41
pubmed: 25873701
Lung Cancer. 2012 Feb;75(2):255-60
pubmed: 21816502
Curr Oncol. 2011 Aug;18(4):e191-201
pubmed: 21874110
Adv Radiat Oncol. 2017 Oct 23;3(1):62-69
pubmed: 29556582
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):654-61
pubmed: 17467926
Head Neck. 2019 Jun;41(6):1667-1675
pubmed: 30701614
Biomed Res Int. 2017;2017:1695101
pubmed: 29387715
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):563-70
pubmed: 27020104
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Oral Oncol. 2017 Nov;74:142-147
pubmed: 29103743
Radiother Oncol. 2014 Jan;110(1):81-90
pubmed: 23953753
Turk Geriatri Derg. 2014;17(2):188-195
pubmed: 25489272
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Head Neck. 2019 Jul;41(7):2410-2429
pubmed: 30737976
J Oncol Pract. 2017 Apr;13(4):e319-e328
pubmed: 28267393
Perspect Clin Res. 2015 Oct-Dec;6(4):184-9
pubmed: 26623388
Anticancer Res. 2017 Apr;37(4):1847-1851
pubmed: 28373450
J Clin Oncol. 2004 Nov 15;22(22):4626-31
pubmed: 15542812
Laryngoscope. 2014 Sep;124(9):2057-63
pubmed: 24591144
Laryngoscope. 2004 Nov;114(11):1915-23
pubmed: 15510014
Arch Otolaryngol Head Neck Surg. 2002 Oct;128(10):1172-9
pubmed: 12365889
Radiother Oncol. 2009 Jul;92(1):4-14
pubmed: 19446902
Laryngoscope. 2008 Mar;118(3):428-32
pubmed: 18043491

Auteurs

Daniel R Dickstein (DR)

Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Marc Egerman (M)

Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Erica Monrose (E)

Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Achintya Varma (A)

Division of Biostatistics, Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Umut Ozbek (U)

Division of Biostatistics, Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Sonam Sharma (S)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Jerry T Liu (JT)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Vishal Gupta (V)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Marshall R Posner (MR)

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Krzysztof Misiukiewicz (K)

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Brett A Miles (BA)

Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Eric Genden (E)

Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Richard L Bakst (RL)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH